CMS has released draft guidance on the Medicare Drug Price Negotiation Program. Comments on the draft guidance are due July 2, and NCPA will be submitting comments. This draft guidance outlines new requirements for the second cycle of negotiations, which begins in 2025 and will result in maximum fair prices (MFPs) effective for 2027.
Healthcare Updates for Medicaid Access, Cyberattack Testimony natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Judge rejects J&J, BMS challenges to Medicare drug pricing program njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.
Navigating the Impact of the Inflation Reduction Act: Assessing Current Realities and Future Trajectory fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.